1. Home
  2. BDTX vs NCTY Comparison

BDTX vs NCTY Comparison

Compare BDTX & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • NCTY
  • Stock Information
  • Founded
  • BDTX 2014
  • NCTY 1999
  • Country
  • BDTX United States
  • NCTY China
  • Employees
  • BDTX N/A
  • NCTY N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • NCTY Business Services
  • Sector
  • BDTX Health Care
  • NCTY Consumer Discretionary
  • Exchange
  • BDTX Nasdaq
  • NCTY Nasdaq
  • Market Cap
  • BDTX 132.5M
  • NCTY 156.7M
  • IPO Year
  • BDTX 2020
  • NCTY 2004
  • Fundamental
  • Price
  • BDTX $2.58
  • NCTY $8.71
  • Analyst Decision
  • BDTX Strong Buy
  • NCTY
  • Analyst Count
  • BDTX 6
  • NCTY 0
  • Target Price
  • BDTX $14.83
  • NCTY N/A
  • AVG Volume (30 Days)
  • BDTX 1.3M
  • NCTY 86.1K
  • Earning Date
  • BDTX 08-05-2025
  • NCTY 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • NCTY N/A
  • EPS Growth
  • BDTX N/A
  • NCTY N/A
  • EPS
  • BDTX 0.09
  • NCTY N/A
  • Revenue
  • BDTX $70,000,000.00
  • NCTY $15,305,175.00
  • Revenue This Year
  • BDTX N/A
  • NCTY N/A
  • Revenue Next Year
  • BDTX N/A
  • NCTY N/A
  • P/E Ratio
  • BDTX $29.29
  • NCTY N/A
  • Revenue Growth
  • BDTX N/A
  • NCTY N/A
  • 52 Week Low
  • BDTX $1.20
  • NCTY $5.75
  • 52 Week High
  • BDTX $6.75
  • NCTY $20.59
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 60.64
  • NCTY 45.75
  • Support Level
  • BDTX $2.43
  • NCTY $7.21
  • Resistance Level
  • BDTX $2.72
  • NCTY $8.25
  • Average True Range (ATR)
  • BDTX 0.18
  • NCTY 0.64
  • MACD
  • BDTX -0.00
  • NCTY 0.12
  • Stochastic Oscillator
  • BDTX 76.11
  • NCTY 69.11

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About NCTY The9 Limited American Depository Shares

The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.

Share on Social Networks: